Objective. The goal of the present study was to examine the relationship between pain and cognition in patients with multiple sclerosis.
Introduction
Multiple sclerosis (MS) is a chronic auto-immune disease affecting the central nervous system, characterized by demyelinization, axonal degeneration, and grey matter damage [1] . The etiology of MS is still unknown. Both genetic and environmental factors seem to play a role [2] . Worldwide approximately 2.1 million patients suffer from MS. MS has a relatively early onset with the highest prevalence between the 20th and 40th years of life. More women than men are affected [3] . MS can be categorized into various subtypes, the most common of which are relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and progressive-relapsing (PRMS) [3, 4] . The course of the disease varies considerably, depending on the subtype [2] .
In most cases, the course of the disease starts with reversible neurological disorders [2] , for example, vision impairments [5] . Approximately 50% of all patients will develop permanent neurological disorders [2] . The present study focuses on a possible relationship between two of these permanent neurological disorders, that is, impairment in cognitive functions and pain.
Cognitive impairment is a well-known consequence of MS [3, 6] , present in 40-65% of patients [7] . Impairment V C 2017 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com in cognitive functions in particular negatively influences quality of life [8] . Characteristic for a decline in cognitive functions in MS are slowness in information processing [9, 10] and an impairment in working memory and episodic memory [9] . Furthermore, executive functions can decline [9, 11] . Executive functions regulate multiple cognitive processes, for example, attention, planning, decision-making, and cognitive flexibility [12] . In addition, mood disorders, for example, depression and anxiety, have been observed [3, 6] .
Another main clinical symptom of MS is pain [13] . Next to cognitive impairment, pain negatively influences quality of life [13] . The recognition and subsequent adequate treatment of chronic pain, irrespective of its etiology, is a substantial problem amongst the elderly [14] . Inadequate treatment of chronic pain [15] may lead to a deterioration of cognitive functions, mediated by, for example, sleep disturbances [15] . Consequently, a decline in cognitive functions may deteriorate patient's ability to communicate about pain [15] . This cascade of events may reduce the patient's quality of life [13] .
Other factors that have a known relationship with pain experience, as well as with cognition, are depression and anxiety [16, 17] . In a recent multicenter study, a close relationship between pain, depression, and anxiety was observed in 650 MS patients [18] . More specifically, anxiety predicted pain independently. A central role of anxiety in the relationship between pain and depression has been observed in another study with MS patients [19] . In that study, more pain was related to a higher level of anxiety, next to a higher level of fatigue and more sleep disturbance. In another study, whether a "cluster" of symptoms, that is, symptoms that belong to each other, could be identified in MS patients was examined [20] . A first cluster, called the "emotional/cognitive symptom cluster," incorporated depression, anxiety, cognitive impairment, and irritability. This cluster was different from other clusters; that is, a second cluster included pain, fatigue, and sleep disturbances, and a third cluster that was paraphrased as a "motor symptom cluster." Also from a pathophysiological point of view, the co-occurrence of, for example, depression and pain can be explained [21] . According to these authors, there is an overlap between central nociceptive and affective pathways, and involved neurotransmitters such as noradrenaline and serotonin.
Concerning pain, several subtypes have been identified, including nociceptive and neuropathic pain [22] . Nociceptive pain is mostly caused by abnormalities in the musculoskeletal system; many patients with MS suffer from lower back pain, which can be caused by painful tonic spasms [22] . Concerning neuropathic pain, there are two types of MS-related neuropathic pain: paroxysmal neuropathic pain, for example, trigeminal neuralgia and Lhermitte's sign, and persistent neuropathic pain, for example, extremity pain [22] .
The existence of a possible relationship between cognition and pain is supported by the fact that some specific brain regions (grey matter) and certain pathways (white matter) are involved in both cognition and pain experience. Concerning grey matter, for example, the hippocampus plays a role in episodic memory [23] , as well as in processing the motivational-affective aspects of pain [24] . The prefrontal cortex plays a role in executive functions [25] and is also responsible for the motivational-affective aspects of pain [26] .
Apart from grey matter neuropathology, there is ample evidence that white matter lesions are also responsible for a decline in various cognitive functions, for example, executive functions [27] and episodic memory [27] . In addition, white matter lesions may lead to deafferentiation pain, also paraphrased as central neuropathic pain [28] .
Considering the neuropathology of both grey and white matter in MS and its possible different effects on pain experience, the goal of the present study is to examine the relationship between cognition, in particular executive functions and episodic memory, and pain in MS patients.
The outcome of the present study is clinically relevant, particularly in case of a negative relationship. In that case, a decline in cognitive functions, for example, communication, may coincide with an increase in pain experience, enhancing the risk for undertreatment of pain.
Methods

Study Design
Cross-sectional.
Participants
The current study consisted of 91 patients with MS and 80 control participants, matched for age. All patients were diagnosed by a neurologist. MS patients were either enrolled and examined at Nieuw Unicum (N ¼ 31), a center for the professional community care of clients with primarily physical disabilities, in Zandvoort, the Netherlands, or from the personal social environment of the investigators (N ¼ 60). For example, the parent of one of the students was a physiotherapist treating MS patients at home. One of these patients participated in a gymnastics club with other MS patients. A number of those patients were also willing to participate in our study. The control participants were also enrolled from the personal environment of the investigators. All neurological comorbidities were noted. The frequency of these comorbidities in the group of MS patients was as follows: cerebrovascular accident (CVA) 1, aphasia 0, hemiplegia/hemiparesis 0, paraplegia 0, quadriplegia 0, epilepsy 2, transient ischemic attack (TIA) 1, traumatic brain injury (TBI) 0, migraine 1, hernia 5. The frequency of comorbidities in the control group was as follows: cerebrovascular accident (CVA) 0, aphasia 0, hemiplegia/ hemiparesis 0, paraplegia 0, quadriplegia 0, epilepsy 1, transient ischemic attack (TIA) 0, traumatic brain injury (TBI) 0, migraine 2, hernia 1. Both patients and controls were tested by well-instructed and trained medical and psychology students. The principle investigator trained each student extensively, and in such a way that each student was able to administer the tests in a most reliable way. 
Age
Global Cognitive Functioning
Global cognitive functioning was assessed by using the Mini Mental State Examination (MMSE) [29] , which evaluates the orientation in time and place, registration, recall, short-term memory and long-term memory, visuomotor capacity, language and praxis, attention, and calculation [30] . It consists of 20 items. The score is presented as a percentage, to correct for possible motor disturbances, in which case certain items (a maximum of three items) of the MMSE could not be administered (minimum score ¼ 0, maximum score ¼ 100). The number of MMSE items that had to be left out the MMSE due to motor disturbances differed per patient. When a percentage of lower than 83% (a score of 83% is identical to a standard MMSE score of 25, with a maximum score of 30) is achieved, one speaks of cognitive decline [31] . There was no minimum threshold of available items. 
Exclusion Criteria
Participants were excluded if they had a history of alcoholism, cerebral trauma, normal pressure hydrocephalus, or disorders of the central nervous system, apart from MS, neoplasms, or disturbances of consciousness.
Medication
The use of the following analgesics was noted (score: 0 ¼ no use, 1 ¼ use) to evaluate the possible influence on pain experience: baclofen, paracetamol, diclofenac, naproxen, ibuprofen, and cannabis. Next to pain medication, also medication prescribed for major comorbidities, for example, cardiovascular diseases, respiratory diseases, and gastrointestinal diseases, was noted.
Only the pain medication was included in the data analysis.
Informed Consent
The study was approved by the local medical ethical committee. The MS patients and control participants were extensively informed about the aim and procedure of the investigation, and they were asked to sign an informed consent. After permission, the neuropsychological tests, the vital sensibility tests, and the pain perception tests were obtained.
Material and Procedure
Mood
Three questionnaires were administered: the Beck Depression Inventory (BDI; minimum score ¼ 0, maximum score ¼ 63) [32, 33] , the SCL-90 anxiety subscale (minimum score ¼ 0, maximum score ¼ 40) [34] , and the SCL-90 depression subscale (minimum score ¼ 0, maximum score ¼ 52) [35] .
Factor analysis showed that the three scales loaded on one component with an explained variance percentage ranging from 0.87 to 0.94. Subsequently, the scores of these three scales were converted into z-scores to obtain a composite domain score for mood (Cronbach's alpha ¼ 0.85).
Pain
Number of Words Chosen-Affective
Number of Words Chosen-Affective (NWC-A) [36] is the affective part of the McGill Pain Questionnaire (Dutch version). This subscale consists of five groups, and each group consists of three affective words. The MS patients and control participants are asked to choose one word out of each group that describes best the pain he or she experiences (minimum score ¼ 0, maximum score ¼ 15). As our patients might suffer from a mild to moderate decline in both cognition and motor capacities, we did not use other parts of the McGill Questionnaire as they appeal either to memory ("pain on most days") or motor functions (visual analogue scale).
Colored Analogue Scale
The Colored Analogue Scale (CAS) [37] is a visual analogue scale, which is applied in two forms: one that measures the intensity of pain (CAS Intensity) and one that measures the suffering from pain (CAS Affect). It has a plastic slide, which can be moved from the bottom (no pain ¼ light pink color) to the top (worst pain ¼ dark red color) to assess participant's pain. On the back, a scale from 0 to 10 has been drawn (score: 0 ¼ no pain, 10 ¼ severe pain) to measure the intensity or suffering from pain adequately.
Faces Pain Scale
The MS patients and control participants indicated how much pain they experienced by choosing one among seven different faces, the Faces Pain Scale (FPS) [38] , each of which has a different expression with an increased feeling of pain (score: 0 ¼ no pain, 6 ¼ severe pain).
A participant was considered "pain free" when the score was 0 on all four pain scales. If a 0 score was indicated at, for example, the CAS Intensity and yet the participant indicated pain on another pain scale, then all scores on the pain scales were noted as missing values.
Factor analysis showed that the four scales loaded on one component with an explained variance percentage ranging from 0.88 to 0.93. Subsequently, the scores of these four scales were converted into z-scores to obtain a composite domain score for pain (Cronbach's alpha ¼ 0.94). As the central nervous system processes pain affect and pain intensity with different neuronal networks, that is, the medial and lateral pain system, respectively [39] , we wanted to compose two pain domains (pain affect and pain intensity) within the group of MS patients with pain.
Factor analysis showed that CAS Intensity and FPS loaded on one component with an explained variance percentage of 0.95. Subsequently, the scores of both scales were converted into z-scores to obtain a pain domain "intensity" (Cronbach's alpha ¼ 0.81). To obtain a pain domain "affect," a factor analysis was performed concerning CAS suffering and NWC-A, resulting in an explained variance percentage of 0.92. Subsequently, the scores on both scales were converted into z-scores (Cronbach's alpha ¼ 0.75).
Cognitive Functions
To evaluate a possible relationship between cognitive functioning, in particular episodic memory and executive functions, and pain, an extensive neuropsychological test battery was administered.
Episodic Memory
The 
Face Recognition of the Rivermead Behavioural Memory Test
The Face Recognition of the Rivermead Behavioural Memory Test (RBMT-faces) [41] tests visual, nonverbal long-term episodic memory. It consists of 10 photos of faces, shown to the subject in a fixed order for approximately five seconds per photo. Subjects were asked to select the original photos with faces out of a set of 20 photos. The number of correct responses was scored, with a maximum score of 20.
Picture Recognition of the Rivermead Behavioural Memory Test
The Picture Recognition of the Rivermead Behavioural Memory Test (RBMT-pictures) [41] measures visual longterm episodic memory. A set of 20 cards with drawn pictures is presented to the subject. Each picture is shown for approximately five seconds. After an interval of approximately five minutes, the subject is asked to indicate which picture has been presented earlier and which picture has not been presented before. The number of correct responses was scored, with a maximum score of 40.
Factor Analysis
Factor Analysis showed that the five neuropsychological tests loaded on one component with an explained variance percentage ranging from 0.71 to 0.84. Subsequently, the scores of all five memory tests were converted into z-scores and averaged to obtain a composite score for the domain "memory." The reliability of this score was calculated, yielding a value for Cronbach's alpha of 0.84.
Executive Functions
Category Fluency
Category Fluency is a Subtest of the Dutch Groninger Intelligence Test [42] . The subject has to name as many words as possible in one minute from two different categories: animals and professions. Scores of correct answers are summed.
The Digit Span Backwards of the Wechsler Memory Test
For the Digit Span Backwards (DSB) of the Wechsler Memory Test [43] , a number of digits is presented to the subject (range ¼ 2-8), who has to repeat the digits backwards. Scores are provided for every correctly repeated string. This task measures verbal working memory [43] .
The Key Search Test of the Behavioural Assesment of the Dysexecutive Syndrome
In the Key Search Test of the Behavioural Assesment of the Dysexecutive Syndrome (BADS) [44] , the subject is asked to draw a path on a representation of a sports field. The path is the way the subject would walk in the fictional situation where he or she has to search for their lost keys without having a clue where they were lost. The Key Search Test requires planning. The maximum score is 16.
The Rule Shift Cards of the Behavioural Assessment of the Dysexecutive Syndrome
The Rule Shift Cards of the Behavioural Assessment of the Dysexecutive Syndrome (BADS) [44] consists of 20 cards, which are shown to the subject. The subject is given the instruction to say "yes" to a red card and "no" to a black card. After the first 20 cards have been shown, the rule changes. The 20 cards are presented again, and now the subject has to say "yes" if the card shown has the same color as the previously shown card and "no" if the color of the card is different. The total amount of mistakes is noted. Scores can range between 0 and 4, with 4 being the best score possible (score 0 ¼ !10 errors, score 1 ¼ 7-9 errors, score 2 ¼ 4-6 errors, score 3 ¼ 1-3 errors, score 4 ¼ 0 errors).
The four tests of executive functioning did load on one separate component with an explained variance percentage ranging from 0.48 to 0.75. Subsequently, the scores of the four tests were converted into z-scores to obtain a domain "executive functions." However, the Cronbach's alpha of 0.56 was too low. Consequently, the four tests are presented separately.
Procedure
The cognitive tests and the pain scales were administered at the same time, in one session. The total duration of all tests was approximately 1 to 1.5 hours. To prevent a bias in data collection, tests that could not be administered in one session because the patient became too tired, for example, were not administered at a later time. As the pain scales were administered at the beginning of each test session, all participants were able to complete these scales. 
Data Analyses
The SPSS-PC program was used for data analyses. As mood levels differed significantly between groups, mood was included as covariate in one univariate analysis of covariance analysis concerning the memory domain and pain and in multivariate analyses of covariance concerning executive functions. The results concerning the relationship between pain, executive functions, and episodic memory were analyzed by a stepwise linear regression analysis. A significance level of P < 0.05 was used. To control for multiple executive function tests, the significance level of P < 0.05 was divided by the number of executive function tests (4), resulting in a significance level of P < 0.01.
Results
Mood
MS patients were shown to have significantly higher levels of depression and anxiety than controls. For means, standard deviations, and Mann-Whitney U tests, see Table 1 .
Cognition
Memory Domain
In univariate analysis of covariance, with mood domain as a covariate, MS patients scored significantly
Pain and Cognition lower on memory tests than the control participants. The means, standard deviations, and F-statistics of each separate memory task are also presented in Table 2 .
Executive Functions
A univariate analysis of covariance was used with mood domain as a covariate. Compared with the control participants, the MS patients showed significantly lower scores on the Digit Span Backward, the Verbal Fluency, and the Rule Shift cards. No significant difference between both groups was found concerning the Key search test (see Table 3 ).
Pain
Univariate analysis of variance with mood domain as a covariate showed significant differences in pain experience between groups. MS patients indicate that they experience more pain on all four pain scales (see Table 4 ).
Pain Medication
Significant differences between the MS patients and the control participants were found for the usage of baclofen, paracetamol (acetaminophen), and cannabis (see Table 5 ).
Relationship Between Pain and Cognition
A possible relationship between pain and cognitive functioning was examined only in those MS patients who suffered from pain (24 MS patients were pain free). The data were analyzed by means of four linear regression analyses.
As the score on the domain Mood was significantly higher in MS patients than in the control participants, we started each analysis with entering the predictor Mood. Subsequently, other predictors were stepwise added, that is, domain Memory, BADS Rule Shift task, BADS Key Search, Digit Span Backward, and Category Fluency.
Pain Intensity (Criterion)
The Relationship between Memory Domain and Pain Intensity
The results show that only the first model, including Mood, appeared to be significant, explaining 12% of variance of pain intensity in MS patients (for further details, see Table 6 ).
The Relationship Between Executive Functions and Pain Intensity
Unlike the Memory domain, Mood explained significantly 21% of the variance of pain intensity. Interestingly, the 10% explained variance by Digit Span Backward showed a trend (for further details, see Table 6 ).
Pain Affect (Criterion)
The Relationship Between Memory Domain and Pain Affect
Again, the results show that only Mood appeared to be significant, explaining 11% of variance of pain affect in MS patients (for further details, please see Table 7 ).
The Relationship Between Executive Functions and Pain Affect
Similar to the Memory domain, only Mood was significant, explaining 15% of the variance of pain affect.
Discussion
The rationale underlying the present study was two-fold. First, cognitive functions are vulnerable in MS and pain is a clinical symptom. Second, several brain regions, such as the hippocampus and the prefrontal cortex, play a role in both cognition, in particular in episodic memory and executive functions, respectively [23, 25] , and pain [26] . Therefore it was hypothesized that a relationship may exist between pain and cognitive functions in MS patients. From a clinical point of view, this hypothesis is especially clinically relevant if the relationship between cognition and pain appears to be negative, that is, more pain in combination with a decline in cognitive functions. In that case, it is argued that a decline in cognitive functions may coincide with an impairment in communicative abilities, enhancing the risk for undertreatment of pain. The main finding of the present study is that we did not find a significant relationship between pain, episodic memory, and executive functions in MS patients, while controlling for mood. More than that, regression analysis showed that mood was the only significant predictor of pain. Of course, we did expect a significant correlation between mood and pain in MS. For example, a positive relationship between depression, anxiety, pain, and spasticity is known in MS patients [45] . Next to spasticity, also physical disabilities due to pain, for example, rheumatoid arthritis, appear to be related to anxiety and depression [46] . More specifically, the relationship between physical disability and quality of life is strengthened by depression and anxiety [47] . In other words, treating depression and anxiety in MS would be clinically relevant. However, the results of a recent meta-analysis showed that pharmacological and psychological interventions adequately reduce only depression; for an effective treatment of anxiety, sufficient data are lacking [48] .
Concerning the relationship between pain and executive functions, only Digit Span Backward, a test for working memory, explained 10% of pain intensity (trend: P < 0.04). As far as we know, only in one study in which midlife women participated was a negative relationship between pain and working memory observed [49] . Of note is that also in that study depressive symptoms had a considerable influence on that relationship.
We can only speculate about a possible explanation of the lack of a relationship between pain and cognition (memory, executive functions). Compared with control participants, MS patients activate different brain areas while performing these tasks, which are not involved in the processing of pain. Indeed, a difference in brain activity during the performance of certain neuropsychological tests has been observed between MS patients and control participants. More specifically, it has been observed that, compared with control participants, mildly to severely cognitively impaired MS patients perform attention tasks, an alertness task, and a working memory task by activating other brain areas, for example, the precuneus and the superior and inferior temporal gyrus [50, 51] . These brain areas are not specifically involved in pain processing. Another study presented similar findings [52] . It investigated MS patients with and without cognitive decline and performed an episodic memory fMRI task to determine hippocampal function. In the group of MS patients without cognitive decline, they found an increased activation of the left anterior cingulate gyrus, left hippocampus, parahippocampal gyri bilaterally, and the cerebellum when compared with healthy controls. In the cognitively impaired MS patients, an increased activation of the right precuneus and the posterior cingulate cortex was found. On the other hand, they found a decreased activation of the right hippocampus and the left and right thalamus [52] . Brain imaging studies examining neuronal circuits involved in the performance of the neuropsychological tests applied in our study are necessary to confirm or reject this explanation. A possible explanation for the relationship between Digit Span Backward and pain intensity (10%; trend: P < 0.04), might be as follows. In MS patients, bilateral parietal atrophy was related to a worse performance in Digit Span Backward [53] . Particularly the parietal lobes are part of the lateral pain system, which is involved in processing the intensity of pain [26] .
An interesting research question to examine in a next study would be to compare the cognitive function of MS patients with and without chronic pain; this was not possible in the present study, considering the small group of pain-free MS patients (N ¼ 24). One might expect a difference in cognitive functions as it has been observed, although in older persons without MS that chronic pain might enhance (further) degeneration of, for example, the prefrontal cortex, essential for executive functions [54, 55] .
Relationship Between Pain and Mood
In the current study, mood was found to be a significant predictor of pain. This finding is in line with previous studies [56,19,57-] . Mood disturbances are very common in patients with multiple sclerosis and have a negative effect on pain experience [56] . Amtmann and colleagues showed a close relationship between pain and depression. Pain experience has a positive correlation with depression severity. Furthermore they stated that it is not very clear yet whether pain has an effect on depression severity or depression has an effect on pain experience [19] . Another study among patients with musculoskeletal pain and depression suggests that pain is an equally strong predictor of depression as depression is a predictor of pain [57] .
Pain in MS and Its Undertreatment
The present study found significant differences in pain experience between MS patients and the control participants. Patients with MS indicated, on all four pain scales, that they experience more pain than control participants. Eighty percent of the MS patients in this study indicated that they have pain. These findings are in line with previous studies, which show that 29% to 86% of MS patients experience pain [58] .
Pain has a great influence on quality of life, mood (for example, anxiety and depression), work and recreation [59] . Consequently, adequate pain treatment is of imminent importance. Within this scope, it is of note that even though MS patients took significantly more pain medication than the control participants, MS patients still indicated that they experience more pain. This finding suggests that treatment of pain in MS patients is not adequate. The present finding is supported by previous studies. Those studies [13, 59] report that even though pain is one of the most prevalent symptoms and already present in an early disease stage, pain treatment is not optimal. They state that as MS patients report more severe pain, there is also more dissatisfaction with its treatment. Also, MS patients are less satisfied with the pain treatment if they suffer from continuous pain in comparison with intermittent pain. An explanation could be that MS patients find it difficult to indicate that they have pain and that they have problems to describe the type of pain, for example, making a distinction between neuropathic and non-neuropathic pain [59] . Furthermore it is difficult to treat pain in patients with MS because a consensus about the optimal treatment is lacking [59] .
Limitations
A first limitation of our study is that our sample was not a randomized sample, extracted from a larger population. A second limitation of the present study is that we could not relate disease stage of MS to pain, mood, and cognition. It might have been interesting to see if pain experience, mood, and cognition differ during the course of the disease. Third, we did not report on CNSactive medication, which might have influenced pain experience in MS patients. A fourth limitation is that we do not have information about the dosage of pain medication the MS patients used. A next limitation is that we did not note what kind of pain the MS patients suffered from. This could be important to treat pain more accurately as the several pain syndromes may need a different treatment [59] . Another shortcoming is the lack of information about sleep quality. This could be important as impaired sleep has a negative influence on cognitive functions like memory, attention, and executive functions [60] . Finally, we assessed possible changes in mood levels at the end of each test session. The rationale was that patients may become tired during the test session and answering questions might require less effort than, for example, the cognitive tests. However, being tired might have negatively influenced their responses to questions about depression [61] .
Conclusion
The main conclusion of the present study is that we could not find a relationship between pain, episodic memory, and executive functions in MS patients. Consequently, we do not know at this moment whether patients with MS who show a progressive decline in cognitive functions, and hence might progressively be less able to communicate about pain, are suffering from less or more pain from their painful conditions.
